🔗 Permalink

Inventor profile of:

Daniel T. Dransfield

City:

Hanson, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2024-09-12

Top Assignees for applications by Daniel T. Dransfield

The entities that hold a legal rights for patent applications filed by inventor Dransfield Daniel T.:

DYAX CORP. 22 Cambridge, MA United States
DYAX CORP. 11 Burlington, MA United States
BRACCO SUISSE SA 9 Manno, Switzerland
BRACCO INTERNATIONAL B.V. 6 Amsterdam, Netherlands
SEAGEN INC. 4 Bothell, WA United States
DYAX CORPORATION 3 Cambridge, MA United States
Dyax Corp. 1 Burlington, MS United States
Dyax Corp. 1 Lexington, MA United States
Seattle Genetics, Inc. 1 Bothell, WA United States

Recent patent applications by Dransfield Daniel T.

Daniel T. Dransfield from Hanson, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-09-12

US20240299352A1

Human necessities

COMBINATION THERAPIES WITH SETD2 INHIBITORS

#2 | 2024-01-04

US20240000962A1

Human necessities

Glycan-Interacting Compounds and Methods of Use

#3 | 2023-01-05

US20230001007A1

Human necessities

Glycan-Interacting Compounds and Methods of Use

#4 | 2020-01-02

US20200000932A1

Human necessities

Glycan-interacting compounds and methods of use

#5 | 2018-11-15

US20180327509A1

Chemistry; metallurgy

Glycan-interacting compounds and methods of use

#6 | 2015-12-31

US20150374843A1

Human necessities

MULTIVALENT CONSTRUCTS FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS

#7 | 2015-08-06

US20150218218A1

Chemistry; metallurgy

Peptides that specifically bind HGF receptor (cMet) and uses thereof

#8 | 2014-11-13

US20140335082A1

Human necessities

Combination therapy comprising an MMP-14 binding protein

#9 | 2014-09-25

US20140286864A1

Human necessities

KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy

#10 | 2014-07-24

US20140205545A1

Human necessities

Multivalent constructs for therapeutic and diagnostic applications

#11 | 2014-07-17

US20140199324A1

Physics

EVALUATING PROTEIN EXPRESSION IN PATIENT STRATIFICATION AND OTHER THERAPEUTIC, DIAGNOSTIC AND PROGNOSTIC METHODS FOR CANCER

#12 | 2014-04-17

US20140107041A1

Chemistry; metallurgy

KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy

#13 | 2013-09-19

US20130244890A1

Physics

EVALUATING MMP EXPRESSION IN PATIENT STRATIFICATION AND OTHER THERAPEUTIC, DIAGNOSTIC AND PROGNOSTIC METHODS FOR CANCER

#14 | 2012-06-07

US20120141473A1

Chemistry; metallurgy

Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins

#15 | 2012-05-03

US20120107231A1

Chemistry; metallurgy

Method for treating breast cancer using antibody binding to MMP-14

#16 | 2012-02-16

US20120039802A1

Chemistry; metallurgy

PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (CMET) AND USES THEREOF

#17 | 2011-12-22

US20110311446A1

Chemistry; metallurgy

Peptides that specifically bind HGF receptor (cMet) and uses thereof

#18 | 2011-11-24

US20110286929A1

Human necessities

Multivalent constructs for therapeutic and diagnostic applications

#19 | 2011-07-07

US20110165145A1

Chemistry; metallurgy

IGF-II/IGF-IIE BINDING PROTEINS

#20 | 2011-03-24

US20110070165A1

Chemistry; metallurgy

Multivalent constructs for therapeutic and diagnostic applications

#21 | 2011-03-10

US20110059105A1

Chemistry; metallurgy

TIE COMPLEX BINDING PROTEINS

#22 | 2010-11-18

US20100291001A1

Chemistry; metallurgy

METALLOPROTEINASE-BINDING PROTEINS

#23 | 2010-10-21

US20100266490A1

Chemistry; metallurgy

Metalloproteinase binding proteins

#24 | 2010-10-14

US20100261875A1

Chemistry; metallurgy

Peptides that specifically bind HGF receptor (CMET) and uses thereof

#25 | 2010-10-14

US20100260672A1

Chemistry; metallurgy

PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (CMET) AND USES THEREOF

#26 | 2010-08-05

US20100196361A1

Chemistry; metallurgy

Method of inhibition of vascular development using an antibody

#27 | 2010-01-07

US20100003195A1

Human necessities

KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy

#28 | 2009-08-13

US20090203060A1

Physics

Evaluating MMP expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancer

#29 | 2009-07-23

US20090186031A1

Chemistry; metallurgy

Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins

#30 | 2008-09-04

US20080213253A1

Chemistry; metallurgy

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

#31 | 2008-07-03

US20080160019A1

Human necessities

SEQUENTIAL COMBINATION THERAPY

#32 | 2007-10-18

US20070243139A1

Chemistry; metallurgy

Multivalent constructs for therapeutic and diagnostic applications

#33 | 2007-09-20

US20070217997A1

Chemistry; metallurgy

Antibodies that bind MMP-14

#34 | 2007-07-26

US20070172428A1

Human necessities

Multivalent constructs for therapeutic and diagnostic applications

#35 | 2007-05-01

US10379287

Multivalent constructs for therapeutic and diagnostic applications

#36 | 2006-03-16

US20060057138A1

Chemistry; metallurgy

Method of inhibition of vascular development using an antibody

#37 | 2006-02-16

US20060036076A1

Chemistry; metallurgy

Metalloproteinase-binding proteins

#38 | 2006-02-02

US20060024297A1

Chemistry; metallurgy

Antibodies to Tie1 ectodomain

#39 | 2005-11-10

US20050250700A1

Chemistry; metallurgy

KDR and VEGF/KDR binding peptides

#40 | 2005-09-29

US20050214859A1

Chemistry; metallurgy

Peptides that specifically bind HGF receptor (cMet) and uses thereof

#41 | 2005-05-12

US20050100963A1

Human necessities

KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy

#42 | 2005-02-03

US20050027105A9

Human necessities

Multivalent constructs for therapeutic and diagnostic applications

InventorID:

445424 ⎘